L.J, B., S, B., T, D., R, M., V, V., A, K., & P.M, d. C. (2016). Neofiscalin A and fiscalin C are potential novel indole alkaloid alternatives for the treatment of multidrugresistant Gram-positive bacterial infections.
Chicago Style (17th ed.) CitationL.J, Bessa, Buttachon S, Dethoup T, Martins R, Vasconcelos V, Kijjoa A, and da Costa P.M. Neofiscalin A and Fiscalin C Are Potential Novel Indole Alkaloid Alternatives for the Treatment of Multidrugresistant Gram-positive Bacterial Infections. 2016.
MLA (8th ed.) CitationL.J, Bessa, et al. Neofiscalin A and Fiscalin C Are Potential Novel Indole Alkaloid Alternatives for the Treatment of Multidrugresistant Gram-positive Bacterial Infections. 2016.
Warning: These citations may not always be 100% accurate.